Opportunity Information: Apply for RFA GH 16 006
Apply for RFA GH 16 006
- The HHS-CDC-HHSCDCERA in the health sector is offering a public funding opportunity titled "Conducting Public Health Research in Kenya" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.326.
- This funding opportunity was created on Jan 14, 2016 and posted on Jan 14, 2016.
- Applicants must submit their applications by Mar 28, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 5 candidate(s).
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "Conducting Public Health Research in Kenya" (Funding Opportunity Number RFA GH 16 006) is a CDC-supported cooperative agreement intended to strengthen and expand public health research activities in Kenya. The central goal is to carry out and closely monitor a broad set of epidemiologic, clinical, and laboratory-based studies focused on human diseases and related public health threats affecting the country. Because it is structured as a cooperative agreement rather than a standard grant, the program is designed for an active partnership model in which CDC is likely to have substantial involvement in shaping priorities, coordinating activities, and overseeing implementation and reporting.
The scope of research areas is intentionally wide to match Kenya's diverse disease burden and public health needs. The opportunity explicitly includes studies on emerging and re-emerging infectious diseases, sexually transmitted infections, zoonotic and vector-borne diseases, respiratory illnesses, hepatic and gastrointestinal infections, acute febrile illnesses, and epidemic-prone diseases. It also emphasizes vaccine-preventable diseases, reflecting the importance of surveillance and evaluation work that can support immunization strategies, outbreak detection, and program impact measurement.
Beyond infectious diseases, the announcement includes several additional domains that broaden the program into cross-cutting public health priorities. These include environmental health issues, neglected tropical diseases, maternal and child health, and non-communicable diseases. The opportunity also calls out birth defects and developmental disabilities, which often require specialized surveillance and research methods, as well as biosafety, which is critical for safe laboratory operations and responsible handling of pathogens. Injury control and prevention is also within the allowable scope, signaling that the cooperative agreement can support research relevant to trauma, road safety, occupational risks, and other injury-related burdens.
Administratively, this is a discretionary funding opportunity under the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (Agency: HHS-CDC, ERA). The CFDA number listed is 93.326. Eligibility is described as unrestricted, meaning it is open to a wide range of entity types, although applicants are advised to check any additional eligibility clarifications that may exist in the full notice text. The opportunity originally posted on January 14, 2016, with a closing date of March 28, 2016 (the current closing date is the same, indicating the competition window did not shift). The announcement anticipates making about five awards. The listed award ceiling is "0," which typically indicates that a specific maximum award amount was not provided in the summary field and would need to be confirmed in the full funding announcement or related budget guidance.
In practical terms, the opportunity is geared toward organizations capable of conducting rigorous field and laboratory research, operating surveillance and monitoring systems, and coordinating multi-disciplinary public health studies in Kenya. Projects supported under this announcement would be expected to generate evidence that improves detection, prevention, and control of priority diseases and conditions, while also supporting safe laboratory practices and broader public health capacity in areas such as outbreak preparedness, maternal and child outcomes, chronic disease trends, and injury prevention.
FAQs: Conducting Public Health Research in Kenya (RFA GH 16 006)
What is the title of this funding opportunity?
The opportunity is titled "Conducting Public Health Research in Kenya."
What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is RFA GH 16 006.
Which agency is offering and supporting this opportunity?
This is a U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (HHS-CDC) discretionary funding opportunity (listed as HHS-CDC, ERA).
What type of funding mechanism is this?
This is a cooperative agreement, not a standard grant.
What does it mean that this is a cooperative agreement?
Because it is a cooperative agreement, the program is set up for an active partnership model. CDC is expected to have substantial involvement in shaping priorities, coordinating activities, and overseeing implementation and reporting.
What is the main goal of the program?
The central goal is to strengthen and expand public health research activities in Kenya by carrying out and closely monitoring a broad set of epidemiologic, clinical, and laboratory-based studies focused on human diseases and related public health threats affecting the country.
Where is the work expected to take place?
The opportunity is focused on conducting public health research in Kenya.
What kinds of studies are supported under this opportunity?
The scope includes a broad set of epidemiologic, clinical, and laboratory-based studies, along with close monitoring of those activities.
Which infectious disease areas are explicitly included?
The announcement explicitly includes research on emerging and re-emerging infectious diseases, sexually transmitted infections, zoonotic and vector-borne diseases, respiratory illnesses, hepatic and gastrointestinal infections, acute febrile illnesses, and epidemic-prone diseases.
Does the opportunity include work on vaccine-preventable diseases?
Yes. Vaccine-preventable diseases are emphasized, including work that can support surveillance and evaluation for immunization strategies, outbreak detection, and measurement of program impact.
Are non-infectious public health topics included in the allowable scope?
Yes. The scope extends beyond infectious diseases and includes environmental health issues, neglected tropical diseases, maternal and child health, non-communicable diseases, birth defects and developmental disabilities, biosafety, and injury control and prevention.
Is environmental health included?
Yes. Environmental health issues are listed as part of the scope.
Are neglected tropical diseases included?
Yes. Neglected tropical diseases are explicitly included.
Does this opportunity cover maternal and child health?
Yes. Maternal and child health is included among the program domains.
Are non-communicable diseases (NCDs) within scope?
Yes. Non-communicable diseases are included as a domain for research activities.
Are birth defects and developmental disabilities included?
Yes. Birth defects and developmental disabilities are specifically called out, which may involve specialized surveillance and research approaches.
Is biosafety part of the program scope?
Yes. Biosafety is included, reflecting the importance of safe laboratory operations and responsible handling of pathogens.
Can injury control and prevention research be supported?
Yes. Injury control and prevention is within the allowable scope, including research relevant to trauma, road safety, occupational risks, and other injury-related burdens.
What is the CFDA number associated with this opportunity?
The CFDA number listed is 93.326.
Who is eligible to apply?
Eligibility is described as unrestricted, meaning it is open to a wide range of entity types. Applicants are advised to check whether the full notice includes any additional eligibility clarifications.
When was the opportunity posted?
The opportunity was originally posted on January 14, 2016.
What is the application closing date?
The closing date listed is March 28, 2016, and the current closing date is the same.
How many awards does the announcement anticipate making?
The announcement anticipates making about five awards.
Is there a stated maximum (ceiling) award amount?
The summary lists an award ceiling of "0," which typically means a specific maximum award amount was not provided in the summary field. The maximum would need to be confirmed in the full funding announcement or related budget guidance.
What types of organizational capabilities does this opportunity seem to require?
Based on the description, it is geared toward organizations able to conduct rigorous field and laboratory research, operate surveillance and monitoring systems, and coordinate multidisciplinary public health studies in Kenya.
What outcomes are projects expected to support?
Projects are expected to generate evidence that improves detection, prevention, and control of priority diseases and conditions, while also supporting safe laboratory practices and broader public health capacity in areas such as outbreak preparedness, maternal and child outcomes, chronic disease trends, and injury prevention.
How involved will CDC be during implementation?
CDC involvement is expected to be substantial, including shaping priorities, coordinating activities, and overseeing implementation and reporting, consistent with a cooperative agreement partnership model.
Browse more opportunities from the same category: Health
Next opportunity: Rural Health Research Center Cooperative Agreement
Previous opportunity: Feed the Future Bangladesh Rice and Diversified Crops Activity
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA GH 16 006
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA GH 16 006) also looked into and applied for these:
| Funding Opportunity |
|---|
| Rural Health Research Center Cooperative Agreement Apply for HRSA 16 054 Funding Number: HRSA 16 054 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| International Bioethics Research Training Program (D43) Apply for PAR 16 082 Funding Number: PAR 16 082 Agency: HHS-NIH11 Category: Health Funding Amount: $230,000 |
| Genome Sequencing Center for the Gabriella Miller Kids First Pediatric Research Program (U24) Apply for RFA RM 16 001 Funding Number: RFA RM 16 001 Agency: HHS-NIH11 Category: Health Funding Amount: $12,600,000 |
| Characterizing the Functional Elements in the Encyclopedia of DNA Elements (ENCODE) Catalog (UM1) Apply for RFA HG 16 003 Funding Number: RFA HG 16 003 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Early Comprehensive Childhood Systems Impact (ECCS Impact) Apply for HRSA 16 047 Funding Number: HRSA 16 047 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Computational Analysis of the Encyclopedia of DNA Elements (ENCODE) Data (U01) Apply for RFA HG 16 004 Funding Number: RFA HG 16 004 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| NIA Clinical Research Project Planning Grant Program (R34) Apply for PAR 16 085 Funding Number: PAR 16 085 Agency: HHS-NIH11 Category: Health Funding Amount: $225,000 |
| ENCODE Data Analysis Center (U24) Apply for RFA HG 16 006 Funding Number: RFA HG 16 006 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Supporting Laboratory Strengthening Activities in Resource-Limited Countries under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH13 1366SUPP15 Funding Number: CDC RFA GH13 1366SUPP15 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Integrated HIV Prevention and Health Services for Key and Priority Populations (HIS-KP) Apply for RFA 656 16 000001 Funding Number: RFA 656 16 000001 Agency: USAID-MOZ Category: Health Funding Amount: $20,000,000 |
| Evaluation of Core State Violence and Injury Prevention Program (Core SVIPP) Apply for CDC RFA CE16 1603 Funding Number: CDC RFA CE16 1603 Agency: HHS-CDC-NCIPC Category: Health Funding Amount: $300,000 |
| ENCODE Data Coordinating Center (U24) Apply for RFA HG 16 005 Funding Number: RFA HG 16 005 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Expanding the Encyclopedia of DNA Elements (ENCODE) in the Human and Mouse (UM1) Apply for RFA HG 16 002 Funding Number: RFA HG 16 002 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Population-based HIV Impact Assessments in Resource-Constrained Settings under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH14 140903CONT16 Funding Number: CDC RFA GH14 140903CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Implementing Evidence Based Prevention Intervention for Key Populations in the Republic of Rwanda under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 161602CONT16 Funding Number: CDC RFA GH15 161602CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Building Complex 3-Dimensional in Vitro Human Musculoskeletal and Skin Tissue Models (R43) Apply for RFA AR 17 005 Funding Number: RFA AR 17 005 Agency: HHS-NIH11 Category: Health Funding Amount: $225,000 |
| Surveillance, Service Data Analysis and Capacity Building to Support Management, Leadership and Sustainability of HIV Programs in Haiti and other Health Initiative under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 152902CONT16 Funding Number: CDC RFA GH15 152902CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Expansion and Strengthening of Clinic-Based HIV Related Services in Haiti under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 153002CONT16 Funding Number: CDC RFA GH15 153002CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Research and Technical Assistance for Public Health Intervention Supporting the National Blood Safety Program in the Implementation and Expansion of Blood Safety Activities in the Republic of Haiti under the President's Emergency Plan for AIDS Relief Apply for CDC RFA GH12 125105CONT16 Funding Number: CDC RFA GH12 125105CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Strengthening Clinical Services for Men Who have Sex with Men, Transgender, and Bisexual Populations Living with HIV/STI in the Dominican Republic under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 162602CONT16 Funding Number: CDC RFA GH15 162602CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA GH 16 006", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.